Prospera Financial Services’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Prospera Financial Services’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-11,310	Closed	-$260K	–	1117
2023 Q4	$260K	Buy	11,310 +563	+5%	+$11.3K	0.01%	905
2023 Q3	$219K	Buy	+10,747	New	+$241K	0.01%	917
2022 Q2	–	Sell	-125	Closed	-$4K	–	2079
2022 Q1	$4K	Buy	+125	New	+$4.42K	﹤0.01%	2320
2021 Q1	–	Sell	-5,702	Closed	-$262K	–	760
2020 Q4	$262K	Buy	5,702 +5,577	+4,462%	+$241K	0.02%	571
2020 Q3	$5K	Buy	+125	New	+$4.81K	﹤0.01%	1287

Other funds holding IDNA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

CCA

Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Prospera Financial Services's IDNA Position: Q1 2024 in Review

Prospera Financial Services sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q1 2024, closing a stake of 11,310 shares — an estimated $260K sold.

Prospera Financial Services first reported a position in IDNA in Q3 2020 and held it in 5 quarters. The position peaked at $262K in Q4 2020. 63 funds tracked by Wall St. Rank hold IDNA as of Q1 2024.

Prospera Financial Services reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q1 2024 after selling out during the quarter.
Prospera Financial Services sold 11,310 iShares Genomics Immunology and Healthcare ETF shares in Q1 2024, an estimated $260K.
Prospera Financial Services first reported a position in iShares Genomics Immunology and Healthcare ETF in Q3 2020 and held it in 5 quarters.
Prospera Financial Services's iShares Genomics Immunology and Healthcare ETF position peaked at $262K in Q4 2020.
63 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2024.

Based on Prospera Financial Services's 13F filing for Q1 2024, filed 13 Aug 2024.